Daré Bioscience Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
23
- Stock Symbol
-
DARE
- Investments
-
4
- Share Price
-
$2.56
- (As of Monday Closing)
Daré Bioscience General Information
Description
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
Contact Information
Website
www.darebioscience.comCorporate Office
- 3655 Nobel Drive
- Suite 260
- San Diego, CA 92122
- United States
Corporate Office
- 3655 Nobel Drive
- Suite 260
- San Diego, CA 92122
- United States
Daré Bioscience Timeline
Daré Bioscience Stock Performance
As of 23-Jun-2025, Daré Bioscience’s stock price is $2.56. Its current market cap is $22.7M with 8.85M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.56 | $2.77 | $2.56 - $5.76 | $22.7M | 8.85M | 22.2K | -$0.17 |
Daré Bioscience Financials Summary
As of 31-Mar-2025, Daré Bioscience has a trailing 12-month revenue of $89.6K.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 11,182 | 17,316 | 16,756 | 30,598 |
| Revenue | 90 | 10 | 2,808 | 10,000 |
| EBITDA | (1,487) | (4,011) | (30,123) | (30,924) |
| Net Income | (1,677) | (4,054) | (30,161) | (30,948) |
| Total Assets | 18,619 | 22,101 | 21,282 | 43,826 |
| Total Debt | 3,573 | 1,303 | 1,404 | 489 |
Daré Bioscience Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Daré Bioscience Comparisons
Industry
Financing
Details
Daré Bioscience Competitors (11)
One of Daré Bioscience’s 11 competitors is Biogen, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Biogen | Formerly VC-backed | Cambridge, MA | ||||
| Pfizer Manufacturing Austria | Corporation | Orth An Der Donau, Austria | ||||
| Bristol-Myers Squibb | Corporation | Princeton, NJ | ||||
| Merck & Co. | Corporation | Rahway, NJ | ||||
| Evofem Biosciences | Formerly VC-backed | San Diego, CA |
Daré Bioscience Patents
Daré Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4376852-A1 | Compositions for use in the treatment of bacterial vaginosis | Pending | 26-Jul-2021 | ||
| EP-4376890-A2 | Compositions for use in the treatment of dysmenorrhea | Pending | 26-Jul-2021 | ||
| AU-2022319690-A1 | Compositions and techniques for vaginal insertion | Pending | 26-Jul-2021 | ||
| US-20240165141-A1 | Systems and methods for treatment of bacterial vaginosis | Pending | 26-Jul-2021 | ||
| US-20240189265-A1 | Compositions and techniques for vaginal insertion | Pending | 26-Jul-2021 | A61K31/196 |
Daré Bioscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Daré Bioscience Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Daré Bioscience Investments & Acquisitions (4)
Daré Bioscience’s most recent deal was a Merger/Acquisition with Microchips Biotech. The deal was made on 20-Nov-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Microchips Biotech | 20-Nov-2019 | Merger/Acquisition | Drug Delivery | ||
| Hydra Biosciences (intellectual property) | 16-Jul-2018 | Corporate Asset Purchase | Buildings and Property | ||
| Pear Tree Pharmaceuticals | 30-Apr-2018 | Merger/Acquisition | Pharmaceuticals | ||
| Cerulean Pharma | 19-Jul-2017 | Merger/Acquisition | Biotechnology |
Daré Bioscience FAQs
-
When was Daré Bioscience founded?
Daré Bioscience was founded in 2005.
-
Where is Daré Bioscience headquartered?
Daré Bioscience is headquartered in San Diego, CA.
-
What is the size of Daré Bioscience?
Daré Bioscience has 23 total employees.
-
What industry is Daré Bioscience in?
Daré Bioscience’s primary industry is Biotechnology.
-
Is Daré Bioscience a private or public company?
Daré Bioscience is a Public company.
-
What is Daré Bioscience’s stock symbol?
The ticker symbol for Daré Bioscience is DARE.
-
What is the current stock price of Daré Bioscience?
As of 23-Jun-2025 the stock price of Daré Bioscience is $2.56.
-
What is the current market cap of Daré Bioscience?
The current market capitalization of Daré Bioscience is $22.7M.
-
What is Daré Bioscience’s current revenue?
The trailing twelve month revenue for Daré Bioscience is $89.6K.
-
Who are Daré Bioscience’s competitors?
Biogen, Pfizer Manufacturing Austria, Bristol-Myers Squibb, Merck & Co., and Evofem Biosciences are some of the 11 competitors of Daré Bioscience.
-
What is Daré Bioscience’s annual earnings per share (EPS)?
Daré Bioscience’s EPS for 12 months was -$0.17.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
